Молимо вас користите овај идентификатор за цитирање или овај линк до ове ставке: https://scidar.kg.ac.rs/handle/123456789/16156
Пун извештај метаподатака
Поље DC-а ВредностЈезик
dc.contributor.authorĐorović Jovanović, Jelena-
dc.contributor.authorMarković, Zoran-
dc.contributor.authorKokanovic, Mihajlo-
dc.contributor.authorFilipovic, Nenad-
dc.contributor.authorStanojevic Pirkovic, Marijana-
dc.date.accessioned2023-02-08T16:35:58Z-
dc.date.available2023-02-08T16:35:58Z-
dc.date.issued2021-
dc.identifier.issn--
dc.identifier.urihttps://scidar.kg.ac.rs/handle/123456789/16156-
dc.description.abstractHeart failure (HF) is a condition that affects mostly older populations. It can be treated with different medications, and one of them is Entresto. This is a medication which is consisting of two drugs, sacubitril (SAC) and valsartan (VAL). Here, in this study, are performed molecular docking simulations in order to examine the inhibitory potency of SAC and VAL towards neprilysin (NEP) and angiotensin II receptor (AT2), respectively. The achieved thermodynamic parameters shows that SAC and VAL can bind to targeted protein, and inhibit NEP and AT2. The best binding sites are determined. Also, the amino acids responsible for binding are identified.-
dc.rightsinfo:eu-repo/semantics/restrictedAccess-
dc.rightsinfo:eu-repo/semantics/restrictedAccess-
dc.rightsinfo:eu-repo/semantics/restrictedAccess-
dc.sourceBIBE 2021 - 21st IEEE International Conference on BioInformatics and BioEngineering, Proceedings-
dc.titleInhibitory potency of Valsartan/Sacubitril drug combination: Molecular docking simulations-
dc.typeconferenceObject-
dc.identifier.doi10.1109/BIBE52308.2021.9635185-
dc.identifier.scopus2-s2.0-85123716698-
Налази се у колекцијама:Faculty of Engineering, Kragujevac
Faculty of Medical Sciences, Kragujevac
Institute for Information Technologies, Kragujevac

Број прегледа

2257

Број преузимања

11

Датотеке у овој ставци:
Датотека Опис ВеличинаФормат 
PaperMissing.pdf
  Ограничен приступ
29.86 kBAdobe PDFСличица
Погледајте


Ставке на SCIDAR-у су заштићене ауторским правима, са свим правима задржаним, осим ако није другачије назначено.